KKR Posts Q2 Adjusted EPS $1.18, $1.86B Revenue, Raises Spectris Offer to $5.6B Amid Bidding War

KKR & Co. Inc. reported strong financial results for the second quarter of 2025, with adjusted earnings per share of $1.18, surpassing estimates of $1.14. The company posted revenue of $1.86 billion and net income of $472 million. Fee-related earnings increased to $887 million, driven by robust fundraising and growth in life sciences, notably through the acquisition of HealthCare Royalty Partners. Assets under management at the end of Q2 reached $686 billion, exceeding expectations. KKR declared a quarterly dividend of $0.185 per share and raised $6.5 billion for asset-backed finance. The firm remains optimistic about its outlook. Additionally, KKR priced $900 million of 5.1% senior notes due in 2035. In a competitive bidding process, KKR raised its offer for British precision testing company Spectris to $5.6 billion, intensifying the contest with rival private equity firm Advent.